SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is facing significant downward pressure as investors react to a dual miss on top and bottom-line earnings and a lack of clear forward guidance. The community is sharply divided, with some investors liquidating positions due to fading confidence in core brand sales, while others view the sell-off as an irrational overreaction and are aggressively adding to their holdings in anticipation of a long-term turnaround.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending after reporting record quarterly revenue that significantly exceeded analyst estimates, accompanied by improved gross margins and potential upward revisions to annual guidance. The stock is generating intense community discussion and high volume as investors monitor potential short covering, upcoming pipeline catalysts, and speculative buyout interest.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is experiencing significant volatility and negative investor sentiment heading into its earnings report, driven by persistent selling pressure and ongoing community comparisons to better-performing ad-tech peers. Shareholders are closely watching for signs of growth or a potential strategic pivot, while short-interest levels and the stock's recent underperformance relative to the broader market remain central points of debate.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is facing extreme volatility after reporting a slight revenue miss and cautious forward guidance, triggering a massive sell-off despite the company's strong year-over-year growth and robust profit margins. The community is sharply divided, with bulls viewing the 20% price drop as an overreaction and a buying opportunity for a cash-flow-positive company, while bears argue that the stock's valuation was unsustainable and that slowing growth is a sign of long-term weakness.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors focus on the upcoming earnings call, specifically seeking clarity on the clinical status of the proprietary COVID-19-Influenza Combination vaccine and the commercial trajectory of the Matrix-M adjuvant platform. Community discussion is polarized between frustration over the lack of near-term partnership announcements and bullish conviction in the long-term value of the company's vaccine technology.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is experiencing heightened volatility following a major lockup expiration, with the community actively debating whether the stock's resilience against selloff pressure signals a bottom or if institutional selling will continue to dampen the rally. Investors remain polarized, with many analyzing the long-term potential of the company's AI infrastructure and space projects versus the immediate risks posed by ongoing share dilution.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened volatility and massive trading volume following a record-breaking earnings report that showed significant revenue growth and improved guidance. Investors are actively debating the potential for a short squeeze, given the stock's high short interest, while community discussions remain sharply divided between those anticipating a major breakout and those warning of a potential pump-and-dump scenario.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros is experiencing high volatility as investors weigh the company's aggressive expansion strategy and strong same-store sales growth against concerns regarding elevated valuations and margin pressure from rising operating costs. The community is actively debating the stock's long-term growth potential versus its high price-to-earnings multiple, with many traders closely monitoring post-earnings price action for signs of a sustained breakout.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is surging toward 52-week highs following strong institutional inflows and positive analyst upgrades that highlight its successful execution in the ACA marketplace. The community is actively discussing the stock's impressive momentum and the potential for a continued run as investors rotate into high-growth healthcare names.

Axon Enterprise, Inc. engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services. The Software and Sensors segment includes devices, wearables, applications, cloud, and mobile products. The company was founded by Patrick W. Smith and Thomas P. Smith on September 7, 1993 and is headquartered in Scottsdale, AZ.

Axon Enterprise Inc

Axon is experiencing a significant pullback following a period of intense volatility and insider selling, leaving the community divided between those who believe the long-term growth story remains intact and those frustrated by the company's high valuation and dilution. Investors are actively debating whether this decline represents a buying opportunity for a high-quality compounder or a continued correction for an overextended software name.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$JAZZ has an FDA decision coming up on August 25 for Ziihera in first-line HER2-positive gastroesophageal cancer. If approved, it would expand the drug into a much larger indication and could become an important growth driver for Jazz. Do you think the FDA approves?

Mike Long

Justin

StockTwits Web

Jazz Pharmaceuticals plc

 has an FDA decision coming up on August 25 for Ziihera in first-line HER2-positive gastroesophageal cancer. If approved, it would expand the drug into a much larger indication and could become an important growth driver for Jazz. Do you think the FDA approves?